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Introduction
The Thousand Genomes Project has revealed the extraor-
dinary scale of human genetic variation such as each per-
son inherits ~12,000 protein-changing single nucleotide
variations (SNVs) including up to 100 premature STOP
codons creating an immense challenge to investigate the
physiological consequence of this type of genetic variation
in experimental animals.
Aim
To develop a new strategy to meet this need by using
whole exome capture, massively parallel DNA sequenc-
ing and computational analysis to sensitively and specifi-
cally identify 40-50 de novo mis-sense SNV mutations
spread across the genome of individual offspring from
ENU-mutagenized C57BL/6 mice [1].
Results
In this presentation we demonstrate how direct se-
quencing of animals with independent defects in B cell
development resulted in the identification of the causa-
tive mutation both in genes of previously known and
unknown function without meiotic mapping. This
approach has resulted in the identification of a new
phospholipid transport pathway that is crucial for nor-
mal B cell development in the bone marrow [2] and the
realization that an endopeptidase of previously unknown
in vivo function is essential for normal processing of
MHC invariant chain and terminal B cell and DC
maturation.
By sequencing animals from defined strains and also
founder animals of ENU mutant pedigrees two generations
before the phenotypic screens we have started to build a
database of missense mutations containing currently close
to 7000 mutations in mouse pedigrees actively breeding
and immediately available for experimental analysis.
All data is made available from the missense variant data-
base (pb.apf.edu.au/phenbank).
Conclusion
This approach transforms mammalian experimental
genetics and opens up an unparalleled source for experi-
mental models of human disease and validation of human
disease associated SNVs.
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